BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-Q Filing
Market Intelligence Analysis
AI-Powered 50% FREE-ANALYSIS-RULE-BASED-ANALYSISAnalysis of stock market developments showing neutral sentiment.
Article Context
HOLMDEL, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTC Markets: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced today that it has received a notification letter from The Nasdaq Stock Market, LLC informing the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange C
AI Breakdown
Summary
Analysis of stock market developments showing neutral sentiment.
Time Horizon
Short Term
Analysis and insights provided by AnalystMarkets AI.